Viewing Study NCT02125461

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:48 AM
Ignite Modification Date: 2026-02-07 @ 11:57 AM
Study NCT ID: NCT02125461
Status: COMPLETED
Last Update Posted: 2023-10-10
First Post: 2014-04-25
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer
Sponsor: AstraZeneca
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Locally advanced View
None Unresectable Non-Small Cell Lung Cancer View
None MEDI4736 View
None PD-L1 View
None Stage III Non-Small Cell Lung Cancer View
None Chemoradiation View
None Immune-mediated cancer therapy View